regulatory approval

News

Boehringer bags FDA okay for new pulmonary fibrosis drug

Boehringer's successor to blockbuster IPF therapy Ofev has been approved by the FDA as Jascayd, but will the new drug be a commercial success?

News

Roche gets EU nod for kidney disease algorithm

Roche and Klinrisk have picked up a CE-mark for an AI tool that can be used to predict renal function decline in patients with chronic kidney disease.

News

Jazz, Roche combo cleared by FDA for lung cancer

Can FDA approval of Jazz Pharma's Zepzelca in a combination regimen for extensive-stage small cell lung cancer return sales of the drug to growth?

News

FDA angers anti-abortion lobby with generic abortion pill OK

The FDA has cleared another generic of the abortion pill mifepristone, as it carries out a review of the drug that has been criticised as spurious.

News

FDA clears Novartis' oral drug for chronic hives

Novartis has claimed a first-in-class approval in the US for its oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria.

News

Lilly brings second oral SERD to market for breast cancer

Lilly's Inluriyo is the second oral SERD to reach the US market for ESR1-mutated breast cancer, setting up a market tussle with Menarini's Orserdu.

Boehringer bags FDA okay for new pulmonary fibrosis drug

Roche gets EU nod for kidney disease algorithm

Jazz, Roche combo cleared by FDA for lung cancer

FDA angers anti-abortion lobby with generic abortion pill OK

FDA clears Novartis' oral drug for chronic hives

Lilly brings second oral SERD to market for breast cancer

Are Makary's priority review vouchers about to be canned?

Securing your ROI: Turning post-acquisition integration into...

regulatory approval

Editor's Picks